Jimmy Carter is reportedly doing well, recovering from surgery for a broken hip sustained after the 94-year-old former president fell at his home. With falls among the top five leading causes of preventable death, context is paramount.
Concluding our two-part series on important melanoma topics, we focus on immunotherapy and the new frontier in the areas of research and treatment by engaging three experts from the Wistar Institute Melanoma Research Center.
Did you know Bob Marley died of melanoma? Or, that Jimmy Carter was recently "cured" of metastatic melanoma? Many misperceptions abound with respect to skin cancer — specifically melanoma — so we will address them here with Part 1 of a two-part series. To debunk myths about who is at risk, discuss hot topics in the field and learn what treatments loom on the horizon, I enlisted the help of three leading melanoma researchers from The Wistar Institute —our nation’s first independent biomedical research facility where I am a member of the leadership council.
In August, Jimmy Carter was diagnosed with melanoma in his liver and brain. These lesions were addressed directly, he was put on Keytruda and now the former president is in remission. But since this new drug costs about $150,000 per year, we ask: Shouldn't we be talking about this?